CEO Anna Gluskin of Eastgate Biotech Corp. discusses in detail strategic alliance with MJ Biopharm, their insulin mouth rinse solution, and how it will help in the treatment of diabetes worldwide.
CEO Earnie Blackmon of United Cannabis Corp., discusses offering testing services in Colorado, growing revenues via industrial hemp processing, and placing processing plants in other States.
CEO Eyal Barad of Cannabics Pharmaceuticals Inc., discusses cancer therapy using cannabinoids, developing patient specific therapies, and the future of the medical cannabis industry.
CEO William Rosellini of Nexeon Medsystems Inc., discusses details of their innovative neurostimulation products, grant for deep brain stimulation, and submission for the FDA innovation challenge.
CEO Chris Bunka of Lexaria Bioscience Corp., talks about their DehydraTECH technology, multiple intellectual property holdings, and the creation of four focused subsidiaries.
CEO Anna Gluskin of Eastgate Biotech Corp., discusses details of recent phase-2 trials for liquid insulin product to treat diabetes.
CEO Anna Gluskin and President Rose Perri of Eastgate Biotech Corp give an update on new offices in the Philippines and plans for 2018.
CEO Chris Bunka of Lexaria Bioscience Corp., discusses bio technology research and their patented drug delivery platform.
CEO Earnie Blackmon of United Cannabis Corp., gives details on biotech and the opening of their hemp processing facility.
CEO Chris Bunka of Lexaria Bioscience Corp., gives an update on patented technology for improved delivery of bioactive compounds.
CEO Dr. Mike Korenko of Advanced Medical Isotope Corp., talks about new brachytherapy tool for the treatment of cancer.
CEO Earnie Blackmon of United Cannabis Corp., discusses development of phytotherapeutic medicines.